Citation Impact
Citing Papers
Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma
2010
Allogeneic Serum Eye Drops for the Treatment of Dry Eye Patients with Chronic Graft-Versus-Host Disease
2012
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
2019 Standout
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Immunoadsorption in dermatology
2010
Zum Stand der Anwendung von Eigenserum-Augentropfen in Deutschland
2008
Enhanced T-Cell Responses to Glioma Cells Coated With the Anti-EGF Receptor Antibody and Targeted to Activating FcγRs on Human Dendritic Cells
2008 StandoutNobel
Identification of SOX2 as a novel glioma-associated antigen and potential target for T cell-based immunotherapy
2007
Myasthenia Gravis
2016 Standout
Gene Therapy-Mediated Reprogramming Tumor Infiltrating T Cells Using IL-2 and Inhibiting NF-κB Signaling Improves the Efficacy of Immunotherapy in a Brain Cancer Model
2012 StandoutNobel
The different roles of the thymus in the pathogenesis of the various myasthenia gravis subtypes
2013
The future of high-grade glioma: Where we are and where are we going
2015
Novel Therapies for Pemphigus Vulgaris
2009
Rituximab in Severe Pemphigus
2009
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Immunoadsorption in Dermatology
2012
Utility of CD127 combined with FOXP3 for identification of operational tolerance after liver transplantation
2016 StandoutNobel
Rituximab in autoimmune bullous diseases: mixed responses and adverse effects
2006
TFOS DEWS II Diagnostic Methodology report
2017 Standout
Elimination of Local Macrophages in Intestine Prevents Chronic Colitis in Interleukin-10-Deficient Mice
2003 StandoutNobel
Complicating autoimmune diseases in myasthenia gravis: a review
2015
The immune contexture in cancer prognosis and treatment
2017 Standout
The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol
2011
Neonatal Fc receptor antagonist efgartigimod safely and sustainably reduces IgGs in humans
2018
TFOS DEWS II pathophysiology report
2017 Standout
The ageing and myasthenic thymus: A morphometric study validating a standard procedure in the histological workup of thymic specimens
2008
Irradiation of necrotic cancer cells, employed for pulsing dendritic cells (DCs), potentiates DC vaccine-induced antitumor immunity against high-grade glioma
2015
Structural Basis for Recognizing Phosphoarginine and Evolving Residue-Specific Protein Phosphatases in Gram-Positive Bacteria
2013 StandoutNobel
TFOS DEWS II Epidemiology Report
2017 Standout
Autoimmune myasthenia gravis: emerging clinical and biological heterogeneity
2009 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Paraneoplastic myasthenia gravis: immunological and clinical aspects
2008
TFOS DEWS II Definition and Classification Report
2017 Standout
Myasthenia gravis
2019 Standout
Dendritic Cell Therapy of High‐Grade Gliomas
2009
Technical advancement in regulatory T cell isolation and characterization using CD127 expression in patients with malignant glioma treated with autologous dendritic cell vaccination
2009
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
New respiratory viral infections
2012
TFOS DEWS II Management and Therapy Report
2017 Standout
Stability of Growth Factors in Autologous Serum Eyedrops After Long-Term Storage
2015
Calreticulin exposure on malignant blasts predicts a cellular anticancer immune response in patients with acute myeloid leukemia
2010
Current therapy of the pemphigus group
2011
Results of a phase I dendritic cell vaccine trial for malignant astrocytoma: potential interaction with adjuvant chemotherapy
2007
Primary brain tumours in adults
2012 Standout
Immunotherapy for the Treatment of Glioblastoma
2012
Therapeutic vaccines for cancer: an overview of clinical trials
2014
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
2009 Standout
Glycocalyx Engineering with a Recycling Glycopolymer that Increases Cell Survival In Vivo
2015 StandoutNobel
Elimination of regulatory T cells is essential for an effective vaccination with tumor lysate‐pulsed dendritic cells in a murine glioma model
2007
DENDRITIC CELL VACCINATION IN PATIENTS WITH MALIGNANT GLIOMAS
2006
The Pathobiology of Vascular Dementia
2013 Standout
Myasthenia gravis and the neuromuscular junction
2013
Thymoma related myasthenia gravis in humans and potential animal models
2015
Treatment of severe pemphigus with protein A immunoadsorption, rituximab and intravenous immunoglobulins
2007
Myasthenia gravis: An emerging toxicity of immune checkpoint inhibitors
2017
ROS and the DNA damage response in cancer
2018 Standout
Clinical and Immunological Follow-Up of Pemphigus Patients on Adjuvant Treatment with Immunoadsorption or Rituximab
2008
Genetic Factors in Autoimmune Myasthenia Gravis
2008
Overview of Cellular Immunotherapy for Patients with Glioblastoma
2010
Immunogenic cell death and DAMPs in cancer therapy
2012 Standout
The Human Cancer Antigen Mesothelin Is More Efficiently Presented to the Mouse Immune System when Targeted to the DEC‐205/CD205 Receptor on Dendritic Cells
2009 StandoutNobel
Myasthenia gravis: subgroup classification and therapeutic strategies
2015 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
Dendritic cell-based active specific immunotherapy for malignant glioma
2007
Association of CTLA‐4 polymorphisms with increased risks of myasthenia gravis
2018
The Combination of Ionizing Radiation and Peripheral Vaccination Produces Long-term Survival of Mice Bearing Established Invasive GL261 Gliomas
2006
Intensified and protective CD4+ T cell immunity in mice with anti–dendritic cell HIV gag fusion antibody vaccine
2006 StandoutNobel
Magnesium in Man: Implications for Health and Disease
2014 Standout
2016 Infectious Diseases Society of America (IDSA) Clinical Practice Guideline for the Treatment of Coccidioidomycosis
2016 Standout
Tyrosine Phosphatase PTPN22: Multifunctional Regulator of Immune Signaling, Development, and Disease
2013
Postoperative Adjuvant Dendritic Cell–Based Immunotherapy in Patients with Relapsed Glioblastoma Multiforme
2008
Loss of the Protein Tyrosine Phosphatase PTPN22 Reduces Mannan-Induced Autoimmune Arthritis in SKG Mice
2016 StandoutNobel
Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System?
2019 Standout
A Synthetic Mimic of Human Fc Receptors: Defined Chemical Modification of Cell Surfaces Enables Efficient Endocytic Uptake of Human Immunoglobulin-G
2006
Evaluation of the Efficacy of 50% Autologous Serum Eye Drops in Different Ocular Surface Pathologies
2014
Challenging the current model of early‐onset myasthenia gravis pathogenesis in the light of the MGTX trial and histological heterogeneity of thymectomy specimens
2018
Cancer Genome Landscapes
2013 StandoutScience
Long-term Use of Autologous Serum 50% Eye Drops for the Treatment of Dry Eye Disease
2014
Clinical Evaluation of Dendritic Cell Vaccination for Patients with Recurrent Glioma: Results of a Clinical Phase I/II Trial
2005
Noncovalent Cell Surface Engineering: Incorporation of Bioactive Synthetic Glycopolymers into Cellular Membranes
2008 StandoutNobel
Glycocalyx Engineering with a Recycling Glycopolymer that Increases Cell Survival In Vivo
2015 StandoutNobel
Impaired T cell receptor signaling and development of T cell–mediated autoimmune arthritis
2020 StandoutNobel
Immunogenic Cell Death in Cancer Therapy
2012 Standout
Works of Andreas Opitz being referenced
Surgery and adjuvant dendritic cell-based tumour vaccination for patients with relapsed malignant glioma, a feasibility study
2004
Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanoma
2012
The PTPN22gain-of-function+1858T(+) genotypes correlate with low IL-2 expression in thymomas and predispose to myasthenia gravis
2009
A CTLA4high genotype is associated with myasthenia gravis in thymoma patients
2005
Late-onset myasthenia gravis – CTLA4low genotype association and low-for-age thymic output of naïve T cells
2014
Stability of Serum Eye Drops After Storage of 6 Months
2012
Improved protocol for treatment of pemphigus vulgaris with protein A immunoadsorption
2006
Recommendations for the use of immunoapheresis in the treatment of autoimmune bullous diseases
2007
High prevalence of antibodies against polyomavirus WU, polyomavirus KI, and human bocavirus in German blood donors
2010
Eigenserum und alternative Blutprodukte zur Behandlung von Augenoberflächenerkrankungen
2008
Protein A immunoadsorption: a novel and effective adjuvant treatment of severe pemphigus
2003
CD8+ T-cell responses to tumor-associated antigens correlate with superior relapse-free survival after allo-SCT
2009
General anesthesia in patients with epilepsy and status epilepticus.
1983